BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brenner A, Arribas M, Cuzick J, Jairath V, Stanworth S, Ker K, Shakur-Still H, Roberts I. Outcome measures in clinical trials of treatments for acute severe haemorrhage. Trials 2018;19:533. [PMID: 30285839 DOI: 10.1186/s13063-018-2900-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Holcomb JB, Moore EE, Sperry JL, Jansen JO, Schreiber MA, Del Junco DJ, Spinella PC, Sauaia A, Brohi K, Bulger EM, Cap AP, Hess JR, Jenkins D, Lewis RJ, Neal MD, Newgard C, Pati S, Pusateri AE, Rizoli S, Russell RT, Shackelford SA, Stein DM, Steiner ME, Wang H, Ward KR, Young P. Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma Trials. Ann Surg 2021;273:395-401. [PMID: 33065652 DOI: 10.1097/SLA.0000000000004563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 9.0] [Reference Citation Analysis]
2 Qureshi AI, Lobanova I, Huang W, Ishfaq MF, Broderick JP, Cassarly CN, Martin RH, Macdonald RL, Suarez JI. Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 2021. [PMID: 34940927 DOI: 10.1007/s12028-021-01372-4] [Reference Citation Analysis]
3 Ageron FX, Gayet-Ageron A, Ker K, Coats TJ, Shakur-Still H, Roberts I; Antifibrinolytics Trials Collaboration. Effect of tranexamic acid by baseline risk of death in acute bleeding patients: a meta-analysis of individual patient-level data from 28 333 patients. Br J Anaesth 2020;124:676-83. [PMID: 32199584 DOI: 10.1016/j.bja.2020.01.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
4 Brenner A, Ker K, Shakur-Still H, Roberts I. Tranexamic acid for post-partum haemorrhage: What, who and when. Best Pract Res Clin Obstet Gynaecol 2019;61:66-74. [PMID: 31128974 DOI: 10.1016/j.bpobgyn.2019.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
5 Dos-santos R, Vilhena-franco T, Reis L, Elias L, Antunes-rodrigues J, Mecawi A. AMPA and angiotensin type 1 receptors are necessary for hemorrhage-induced vasopressin secretion. Braz J Med Biol Res 2022;55:e11635. [DOI: 10.1590/1414-431x2021e11635] [Reference Citation Analysis]
6 Roberts I, Shakur-Still H, Afolabi A, Akere A, Arribas M, Austin E, Bal K, Bazeer N, Beaumont D, Brenner A, Carrington L, Chaudhri R, Coats T, Gilmore I, Halligan K, Hussain I, Jairath V, Javaid K, Kayani A, Lisman T, Mansukhani R, Miners A, Mutti M, Nadeem MA, Pollok R, Prowse D, Simmons J, Stanworth S, Veitch A, Williams J. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT. Health Technol Assess 2021;25:1-86. [PMID: 34663491 DOI: 10.3310/hta25580] [Reference Citation Analysis]
7 Brenner A, Belli A, Chaudhri R, Coats T, Frimley L, Jamaluddin SF, Jooma R, Mansukhani R, Sandercock P, Shakur-Still H, Shokunbi T, Roberts I; CRASH-3 trial collaborators. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial. Crit Care 2020;24:560. [PMID: 33172504 DOI: 10.1186/s13054-020-03243-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Brenner A, Afolabi A, Ahmad SM, Arribas M, Chaudhri R, Coats T, Cuzick J, Gilmore I, Hawkey C, Jairath V, Javaid K, Kayani A, Mutti M, Nadeem MA, Shakur-Still H, Stanworth S, Veitch A, Roberts I; HALT-IT Trial Collaborators. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. Trials 2019;20:467. [PMID: 31362765 DOI: 10.1186/s13063-019-3561-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
9 Curry N, Foley C, Wong H, Mora A, Curnow E, Zarankaite A, Hodge R, Hopkins V, Deary A, Ray J, Moss P, Reed MJ, Kellett S, Davenport R, Stanworth S. The application of a haemorrhage assessment tool in evaluating control of bleeding in a pilot trauma haemorrhage trial. Transfus Med 2019;29:454-9. [PMID: 31680331 DOI: 10.1111/tme.12644] [Reference Citation Analysis]
10 Spinella PC, El Kassar N, Cap AP, Kindzelski AL, Almond CS, Barkun A, Gernsheimer TB, Goldstein JN, Holcomb JB, Iorio A, Jensen DM, Key NS, Levy JH, Mayer SA, Moore EE, Stanworth SJ, Lewis RJ, Steiner ME; Hemostasis Trials Outcomes Working Group. Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference. J Trauma Acute Care Surg 2021;91:S19-25. [PMID: 34039915 DOI: 10.1097/TA.0000000000003300] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. Lancet 2020;395:1927-36. [PMID: 32563378 DOI: 10.1016/S0140-6736(20)30848-5] [Cited by in Crossref: 93] [Cited by in F6Publishing: 38] [Article Influence: 46.5] [Reference Citation Analysis]
12 Wang X, Ma L, Song J, You C. Tranexamic Acid for Adult Patients with Spontaneous Intracerebral Hemorrhage: A Systematic Review with Meta-analysis. CNS Drugs 2021;35:1163-72. [PMID: 34661872 DOI: 10.1007/s40263-021-00865-2] [Reference Citation Analysis]
13 Fabes J, Brunskill SJ, Curry N, Doree C, Stanworth SJ. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia. Cochrane Database Syst Rev 2018;12:CD010649. [PMID: 30582172 DOI: 10.1002/14651858.CD010649.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
14 Nishijima DK, Gosdin M, Naz H, Tancredi DJ, Hewes HA, Myers SR, Stanley RM, Adelson PD, Burd RS, Finkelstein Y, VanBuren J, Casper TC, Kuppermann N; TIC-TOC Collaborators of the Pediatric Emergency Care Applied Research Network (PECARN). Assessment of primary outcome measures for a clinical trial of pediatric hemorrhagic injuries. Am J Emerg Med 2021;43:210-6. [PMID: 32278572 DOI: 10.1016/j.ajem.2020.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Moore EE, Moore HB, Kornblith LZ, Neal MD, Hoffman M, Mutch NJ, Schöchl H, Hunt BJ, Sauaia A. Trauma-induced coagulopathy. Nat Rev Dis Primers 2021;7:30. [PMID: 33927200 DOI: 10.1038/s41572-021-00264-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]